Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Newey

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Endocrinology and Metabolism Clinics of North America|November 14, 2021
Hereditary Primary HyperparathyroidismPaul J Newey
Clinical Endocrinology|June 30, 2019
Clinical genetic testing in endocrinology: Current concepts and contemporary challengesPaul J Newey
Clinical Endocrinology|August 23, 2022
Approach to the patient with a variant of uncertain significance on genetic testingPaul J Newey
Journal of the Endocrine Society|January 26, 2022
MEN1 Surveillance Guidelines: Time to (Re)Think?Paul J Newey, John Newell-Price
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 2, 2011
Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practicePaul J Newey, Rajesh V Thakker
Journal of Molecular Endocrinology|November 29, 2022
Identification of prolactin receptor variants with diverse effects on receptor signallingCaroline M Gorvin, Paul J Newey, Rajesh V Thakker
The Journal of Clinical Endocrinology and Metabolism|April 6, 2023
Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in ScotlandEnrique Soto-Pedre, Paul J Newey, Graham P Leese
The Lancet. Diabetes & Endocrinology|July 14, 2015
Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1Christopher J Yates, Paul J Newey, Rajesh V Thakker
Clinical Endocrinology|December 22, 2021
Genetics of monogenic disorders of calcium and bone metabolismPaul J Newey, Fadil M Hannan, Abbie Wilson, et al.
Human Mutation|January 7, 2010
Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumorsPaul J Newey, Michael R Bowl, Treena Cranston, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Endocrinology and Metabolism Clinics of North America|November 14, 2021
Hereditary Primary HyperparathyroidismPaul J Newey
Clinical Endocrinology|June 30, 2019
Clinical genetic testing in endocrinology: Current concepts and contemporary challengesPaul J Newey
Clinical Endocrinology|August 23, 2022
Approach to the patient with a variant of uncertain significance on genetic testingPaul J Newey
Journal of the Endocrine Society|January 26, 2022
MEN1 Surveillance Guidelines: Time to (Re)Think?Paul J Newey, John Newell-Price
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 2, 2011
Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practicePaul J Newey, Rajesh V Thakker
Journal of Molecular Endocrinology|November 29, 2022
Identification of prolactin receptor variants with diverse effects on receptor signallingCaroline M Gorvin, Paul J Newey, Rajesh V Thakker
The Journal of Clinical Endocrinology and Metabolism|April 6, 2023
Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in ScotlandEnrique Soto-Pedre, Paul J Newey, Graham P Leese
The Lancet. Diabetes & Endocrinology|July 14, 2015
Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1Christopher J Yates, Paul J Newey, Rajesh V Thakker
Clinical Endocrinology|December 22, 2021
Genetics of monogenic disorders of calcium and bone metabolismPaul J Newey, Fadil M Hannan, Abbie Wilson, et al.
Human Mutation|January 7, 2010
Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumorsPaul J Newey, Michael R Bowl, Treena Cranston, et al.
Pageof 3